BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 29678491)

  • 1. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy.
    Patel S
    J Steroid Biochem Mol Biol; 2018 Sep; 182():27-36. PubMed ID: 29678491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS).
    Li Y; Chen C; Ma Y; Xiao J; Luo G; Li Y; Wu D
    Life Sci; 2019 Jul; 228():167-175. PubMed ID: 31029778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine characteristics of polycystic ovary syndrome (PCOS).
    Szilágyi A; Szabó I
    Indian J Exp Biol; 2003 Jul; 41(7):694-700. PubMed ID: 15255372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome and female reproduction.
    Elghblawi E
    Br J Nurs; 2007 Oct 11-24; 16(18):1118-21. PubMed ID: 18073681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Low Grade Inflammation in Pathogenesis of PCOS.
    Rudnicka E; Suchta K; Grymowicz M; Calik-Ksepka A; Smolarczyk K; Duszewska AM; Smolarczyk R; Meczekalski B
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review.
    Carvalho LML; Dos Reis FM; Candido AL; Nunes FFC; Ferreira CN; Gomes KB
    Endocr Regul; 2018 Oct; 52(4):208-221. PubMed ID: 31517612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome, obesity and reproductive implications.
    Hirschberg AL
    Womens Health (Lond); 2009 Sep; 5(5):529-40; quiz 541-2. PubMed ID: 19702452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome.
    Wang J; Wu D; Guo H; Li M
    Life Sci; 2019 Nov; 236():116940. PubMed ID: 31604107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls.
    Lanzo E; Monge M; Trent M
    Pediatr Ann; 2015 Sep; 44(9):e223-30. PubMed ID: 26431241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental models of polycystic ovary syndrome: An update.
    Divyashree S; Janhavi P; Ravindra PV; Muthukumar SP
    Life Sci; 2019 Nov; 237():116911. PubMed ID: 31606385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and polycystic ovary syndrome.
    Naderpoor N; Shorakae S; Joham A; Boyle J; De Courten B; Teede HJ
    Minerva Endocrinol; 2015 Mar; 40(1):37-51. PubMed ID: 25411807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of Chronic Low-Grade Inflammation in the Pathophysiology of Polycystic Ovary Syndrome.
    Shorakae S; Teede H; de Courten B; Lambert G; Boyle J; Moran LJ
    Semin Reprod Med; 2015 Jul; 33(4):257-69. PubMed ID: 26132930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
    Svendsen PF; Nilas L; Nørgaard K; Madsbad S
    Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardiometabolic effect of current management of polycystic ovary syndrome: strategies of prevention and treatment.
    Baldani DP; Skrgatic L; Ougouag R; Kasum M
    Gynecol Endocrinol; 2018 Feb; 34(2):87-91. PubMed ID: 28944709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.